Avricore Health Inc.
AVCR.V
TSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 14.72% | -8.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.72% | -8.41% | |||
| Cost of Revenue | 13.11% | 3.92% | |||
| Gross Profit | 17.64% | -24.64% | |||
| SG&A Expenses | 97.85% | -3.62% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 39.11% | 1.47% | |||
| Operating Income | -319.85% | -60.77% | |||
| Income Before Tax | -432.41% | -68.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -432.41% | -68.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -432.41% | -68.40% | |||
| EBIT | -319.85% | -60.77% | |||
| EBITDA | -123.82% | -37.93% | |||
| EPS Basic | -425.00% | -69.23% | |||
| Normalized Basic EPS | -500.00% | -71.43% | |||
| EPS Diluted | -425.00% | -69.23% | |||
| Normalized Diluted EPS | -500.00% | -71.43% | |||
| Average Basic Shares Outstanding | 0.53% | 0.13% | |||
| Average Diluted Shares Outstanding | -4.93% | 5.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||